Training Course - Overview
Training Course
Overview
We are pleased to present the Haematology Nurses Training Course (in resource restricted environments) which content has been contributed to by the most experienced and academic haematology nurses in South Africa. This means that the content is local and relevant and of an extremely high standard. As we know, in South Africa there is a great divide between the private & state sector, and therefore we address this dichotomy of haematology nursing in these different environments.
This theoretical, online course is designed for nurses and allied healthcare workers who work in haematology units and wards. In fact, the course is open to anyone who would like to become proficient and gain a greater understanding of Haematology basics.
This course has been edited by a panel of haematologists and is endorsed by the two Haematology Associations in SA: SACHAS (South African Clinical Haematology Society) and SASCeTS (South Africa Stem Cell Transplant Society). The final accreditation is by Prof. Estelle Verburgh, Associate Professor and Specialist Consultant, Clinical Haematology, Department of Medicine, University of Cape Town and Groote Schuur Hospital. Professor Vernon Louw, Chair and Head Division of Clinical Haematology Department of Medicine has recommended this course for all nurses who work with Haematology patients.
This course has been sponsored by Accord Pharmaceuticals, for which we are extremely grateful.
A WORD FROM OUR SPONSOR
Accord Healthcare is proud to be working with IGAZI to introduce the first Nurses Haematology Course in South Africa.
With an extensive presence in all regions of the world, Accord Healthcare has very rapidly become one of the fastest growing generic pharmaceutical companies.
Our robust product portfolio in growth-oriented therapies allows us to compete with some of the biggest portfolios in the industry, as well as helping to extend our presence into new markets.
Accord’s operations began with a strategic vision to create a global brand, supported by a commercial infrastructure that enables us to bring our high quality yet affordable products to patients around the world.
We commit ourselves to challenging the unmet medical, societal, and patient needs of the day.